Management and Outcomes of Idiopathic Intracranial Hypertension with Moderate-Severe Visual Field Loss: Pilot Data for the Surgical Idiopathic Intracranial Hypertension Treatment Trial

The management of idiopathic intracranial hypertension (IIH) remains controversial. The Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) is investigating medical intervention (weight loss +/- acetazolamide) for newlydiagnosed IIH patients with baseline mean deviation (MD) between -2 dB -7.00 dB on automated perimetry with Humphrey Field Analyzer (HFA). We collected pilot data on management and outcomes of IIH patients with moderate to severe visual field loss at presentation, in preparation for the Surgical IIH Treatment Trial.CLiiht